Revolutionizing Liver Disease Treatment: BullFrog AI’s Groundbreaking Data on BF-114
BullFrog AI Holdings Announces Breakthrough Research in Treating Liver Diseases Introduction On October 9, 2024, BullFrog AI Holdings, Inc. revealed exciting news in the field of drug development. The company, known for its innovative use of artificial intelligence (AI) and machine learning in pharmaceutical research, unveiled a promising new drug candidate, BF-114 (SPTBN1 siRNA), for…